Panos Z. Anastasiadis

机构：Jacksonville College, Mayo Clinic in Florida · ORCID：0000-0003-4436-9435

发表论文 105 篇 · 总被引 6697 次 · h-index 40

代表论文

• A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872 (2019 · Cancer · 被引 70)
• Three-dimensional microscale hanging drop arrays with geometric control for drug screening and live tissue imaging (2021 · Science Advances · 被引 68)
• Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment (2023 · Frontiers in Cell and Developmental Biology · 被引 51)
• Efficacy of the MDM2 Inhibitor SAR405838 in Glioblastoma Is Limited by Poor Distribution Across the Blood–Brain Barrier (2018 · Molecular Cancer Therapeutics · 被引 41)
• Evolving Role of Oncolytic Virotherapy: Challenges and Prospects in Clinical Practice (2021 · JCO Precision Oncology · 被引 33)
• Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth (2018 · Journal of Experimental & Clinical Cancer Research · 被引 30)